CHINA PHARMA HOLDINGS, INC. General and Administrative Expense
CHINA PHARMA HOLDINGS, INC. (CPHI) reported General and Administrative Expense of $1.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. general and administrative expense for the quarter ending 2026-06-30 was $1.38M, a 212.36% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. general and administrative expense for the quarter ending 2026-03-31 was $1.23M, a 141.78% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. general and administrative expense for the quarter ending 2025-12-31 was $1.08M, a 25.51% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. general and administrative expense for the quarter ending 2025-09-30 was $424.83K, a 23.12% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. general and administrative expense for fiscal 2025 was $2.45M, a 37.36% increase from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. general and administrative expense for fiscal 2024 was $1.78M, a 21.74% increase from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. general and administrative expense for fiscal 2023 was $1.47M, a 22.56% decline from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. general and administrative expense for fiscal 2022 was $1.89M, a 14.67% increase from fiscal 2021.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 3 month as first filed | General and Administrative Expense 6 month | General and Administrative Expense 6 month as first filed | General and Administrative Expense 9 month | General and Administrative Expense 9 month as first filed | General and Administrative Expense 12 month | General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.38M 10-Q · filed 2026-08-14 | $2.60M 10-Q · filed 2026-08-14 | $3.68M derived: sum of 3 quarters · filed 2026-08-14 | $4.11M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $1.23M 10-Q · filed 2026-05-15 | $2.30M derived: sum of 2 quarters · filed 2026-05-15 | $2.73M derived: sum of 3 quarters · filed 2026-05-15 | $3.17M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $1.50M derived: sum of 2 quarters · filed 2026-04-01 | $1.94M derived: sum of 3 quarters · filed 2026-08-14 | $2.45M 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | $424.83K 10-Q · filed 2025-11-12 | $865.66K derived: sum of 2 quarters · filed 2026-08-14 | $1.37M 10-Q · filed 2025-11-12 | $2.23M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $440.83K 10-Q · filed 2026-08-14 | $948.02K 10-Q · filed 2026-08-14 | $1.81M derived: sum of 3 quarters · filed 2026-08-14 | $2.15M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $507.18K 10-Q · filed 2026-05-15 | $1.37M derived: sum of 2 quarters · filed 2026-05-15 | $1.71M derived: sum of 3 quarters · filed 2026-05-15 | $1.80M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $859.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $1.20M derived: sum of 2 quarters · filed 2026-04-01 | $1.30M derived: sum of 3 quarters · filed 2026-04-01 | $1.78M 10-K · filed 2026-04-01 | ||||
| 2024-09-30 | $345.05K 10-Q · filed 2025-11-12 | $436.92K derived: sum of 2 quarters · filed 2025-11-12 | $925.38K 10-Q · filed 2025-11-12 | $1.62M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $91.87K 10-Q · filed 2025-08-14 | $580.33K 10-Q · filed 2025-08-14 | $1.27M derived: sum of 3 quarters · filed 2025-08-14 | $1.52M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $488.46K 10-Q · filed 2025-05-14 | $1.18M derived: sum of 2 quarters · filed 2025-05-14 | $1.42M derived: sum of 3 quarters · filed 2025-05-14 | $1.54M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $689.78K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $936.05K derived: sum of 2 quarters · filed 2025-03-31 | $1.05M derived: sum of 3 quarters · filed 2025-03-31 | $1.47M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $246.27K 10-Q · filed 2024-11-13 | $358.30K derived: sum of 2 quarters · filed 2024-11-13 | $776.30K 10-Q · filed 2024-11-13 | $1.61M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $112.03K 10-Q · filed 2024-08-14 | $530.03K 10-Q · filed 2024-08-14 | $1.36M derived: sum of 3 quarters · filed 2024-08-14 | $1.64M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $418.00K 10-Q · filed 2023-05-12 | $1.25M derived: sum of 2 quarters · filed 2024-04-01 | $1.52M derived: sum of 3 quarters · filed 2024-04-01 | $1.80M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-12-31 | $829.43K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.11M derived: sum of 2 quarters · filed 2024-04-01 | $1.38M derived: sum of 3 quarters · filed 2024-04-01 | $1.89M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $276.61K 10-Q · filed 2023-11-13 | $549.67K derived: sum of 2 quarters · filed 2023-11-13 | $1.06M 10-Q · filed 2023-11-13 | $1.67M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $273.06K 10-Q · filed 2023-08-14 | $787.22K 10-Q · filed 2023-08-14 | $1.40M derived: sum of 3 quarters · filed 2023-08-14 | $1.70M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $514.17K 10-Q · filed 2023-05-12 | $1.12M derived: sum of 2 quarters · filed 2023-05-12 | $1.43M derived: sum of 3 quarters · filed 2023-05-12 | $1.76M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $610.30K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $912.27K derived: sum of 2 quarters · filed 2023-03-30 | $1.24M derived: sum of 3 quarters · filed 2023-03-30 | $1.65M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $301.97K 10-Q · filed 2022-11-14 | $631.73K derived: sum of 2 quarters · filed 2022-11-14 | $1.04M 10-Q · filed 2022-11-14 | $1.86M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $329.76K 10-Q · filed 2022-08-11 | $738.76K 10-Q · filed 2022-08-11 | $1.56M derived: sum of 3 quarters · filed 2022-08-11 | $1.85M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $409.00K 10-Q · filed 2022-05-12 | $1.23M derived: sum of 2 quarters · filed 2022-05-12 | $1.52M derived: sum of 3 quarters · filed 2022-05-12 | $1.84M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $821.07K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.11M derived: sum of 2 quarters · filed 2022-03-30 | $1.43M derived: sum of 3 quarters · filed 2022-03-30 | $1.82M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $290.59K 10-Q · filed 2021-11-12 | $613.03K derived: sum of 2 quarters · filed 2021-11-12 | $1.00M 10-Q · filed 2021-11-12 | $2.19M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $322.44K 10-Q · filed 2021-08-13 | $711.00K 10-Q · filed 2021-08-13 | $1.90M derived: sum of 3 quarters · filed 2021-08-13 | $2.24M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $388.56K 10-Q · filed 2021-05-14 | $1.58M derived: sum of 2 quarters · filed 2021-05-14 | $1.91M derived: sum of 3 quarters · filed 2021-05-14 | $2.25M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $1.53M derived: sum of 2 quarters · filed 2021-03-26 | $1.86M derived: sum of 3 quarters · filed 2021-03-26 | $2.29M 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | $333.83K 10-Q · filed 2020-11-13 | $668.38K derived: sum of 2 quarters · filed 2020-11-13 | $1.10M 10-Q · filed 2020-11-13 | $1.87M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $334.55K 10-Q · filed 2020-08-13 | $763.37K 10-Q · filed 2020-08-13 | $1.54M derived: sum of 3 quarters · filed 2020-08-13 | $1.87M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $428.82K 10-Q · filed 2020-05-14 | $1.21M derived: sum of 2 quarters · filed 2020-05-14 | $1.53M derived: sum of 3 quarters · filed 2020-05-14 | $1.89M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $777.61K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.10M derived: sum of 2 quarters · filed 2020-03-30 | $1.46M derived: sum of 3 quarters · filed 2020-03-30 | $1.95M 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $327.16K 10-Q · filed 2019-11-14 | $680.30K derived: sum of 2 quarters · filed 2019-11-14 | $1.17M 10-Q · filed 2019-11-14 | $1.81M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $353.14K 10-Q · filed 2019-08-14 | $845.15K 10-Q · filed 2019-08-14 | $1.49M derived: sum of 3 quarters · filed 2019-08-14 | $1.84M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $492.01K 10-Q · filed 2019-05-14 | $1.13M derived: sum of 2 quarters · filed 2019-05-14 | $1.48M derived: sum of 3 quarters · filed 2019-05-14 | $2.10M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $642.31K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $991.27K derived: sum of 2 quarters · filed 2019-03-28 | $1.60M derived: sum of 3 quarters · filed 2019-03-28 | $2.02M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $348.96K 10-Q · filed 2018-11-14 | $960.91K derived: sum of 2 quarters · filed 2018-11-14 | $1.38M 10-Q · filed 2018-11-14 | $2.25M derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $611.95K 10-Q · filed 2018-08-14 | $1.03M 10-Q · filed 2018-08-14 | $1.90M derived: sum of 3 quarters · filed 2018-08-14 | $2.19M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $416.73K 10-Q · filed 2018-05-14 | $1.29M derived: sum of 2 quarters · filed 2018-05-14 | $1.58M derived: sum of 3 quarters · filed 2018-05-14 | $2.36M derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $871.60K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $1.17M derived: sum of 2 quarters · filed 2018-04-02 | $1.95M derived: sum of 3 quarters · filed 2018-04-02 | $2.27M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $294.37K 10-Q · filed 2017-11-14 | $1.08M derived: sum of 2 quarters · filed 2017-11-14 | $1.39M 10-Q · filed 2017-11-14 | $1.97M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $780.95K 10-Q · filed 2017-08-14 | $1.10M 10-Q · filed 2017-08-14 | $1.68M derived: sum of 3 quarters · filed 2017-08-14 | $2.06M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $318.93K 10-Q · filed 2017-05-11 | $899.62K derived: sum of 2 quarters · filed 2017-05-11 | $1.28M derived: sum of 3 quarters · filed 2017-05-11 | $1.74M derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $580.69K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $965.10K derived: sum of 2 quarters · filed 2017-03-31 | $1.42M derived: sum of 3 quarters · filed 2017-03-31 | $1.90M 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | $384.41K 10-Q · filed 2016-11-14 | $843.44K derived: sum of 2 quarters · filed 2016-11-14 | $1.32M 10-Q · filed 2016-11-14 | $1.80M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $459.03K 10-Q · filed 2016-08-11 | $931.46K 10-Q · filed 2016-08-11 | $1.42M derived: sum of 3 quarters · filed 2016-08-11 | $1.84M derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | $472.43K 10-Q · filed 2016-05-16 | $959.70K derived: sum of 2 quarters · filed 2016-05-16 | $1.38M derived: sum of 3 quarters · filed 2016-05-16 | $1.77M derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | $487.27K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $910.00K derived: sum of 2 quarters · filed 2016-03-30 | $1.29M derived: sum of 3 quarters · filed 2016-03-30 | $1.72M 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $422.73K 10-Q · filed 2015-12-28 | $805.56K derived: sum of 2 quarters · filed 2015-12-28 | $1.23M 10-Q · filed 2015-12-28 | $2.10M derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2014-06-30 | $382.83K 10-Q · filed 2015-12-28 | $806.76K 10-Q · filed 2015-12-28 | $1.67M derived: sum of 3 quarters · filed 2015-12-28 | $2.05M derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2014-03-31 | $423.93K 10-Q · filed 2015-12-28 | $1.29M derived: sum of 2 quarters · filed 2015-12-28 | $1.66M derived: sum of 3 quarters · filed 2015-12-28 | $2.26M derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2013-12-31 | $867.51K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | $1.24M derived: sum of 2 quarters · filed 2015-12-28 | $1.83M derived: sum of 3 quarters · filed 2015-12-28 | $2.40M 10-K · filed 2015-12-28 | ||||
| 2013-09-30 | $372.57K 10-Q · filed 2014-11-14 | $725.17K 10-Q · filed 2013-11-14 | $963.82K derived: sum of 2 quarters · filed 2014-11-14 | $1.54M 10-Q · filed 2014-11-14 | $2.92M 10-Q · filed 2013-11-14 | $2.32M derived: sum of 4 quarters · filed 2014-11-14 | ||
| 2013-06-30 | $591.25K 10-Q · filed 2014-08-14 | $1.46M 10-Q · filed 2013-08-14 | $1.16M 10-Q · filed 2014-08-14 | $2.20M 10-Q · filed 2013-08-14 | $1.95M derived: sum of 3 quarters · filed 2014-08-14 | $2.55M derived: sum of 4 quarters · filed 2014-08-14 | ||
| 2013-03-31 | $573.01K 10-Q · filed 2014-05-15 | $739.43K 10-Q · filed 2013-05-14 | $1.36M derived: sum of 2 quarters · filed 2014-05-15 | $1.96M derived: sum of 3 quarters · filed 2014-05-15 | $2.77M derived: sum of 4 quarters · filed 2014-05-15 | |||
| 2012-12-31 | $787.24K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $1.39M derived: sum of 2 quarters · filed 2014-03-20 | $2.20M derived: sum of 3 quarters · filed 2014-03-20 | $2.87M 10-K · filed 2014-03-20 | $3.31M 10-K · filed 2013-03-14 | |||
| 2012-09-30 | $598.26K 10-Q · filed 2013-11-14 | $1.41M derived: sum of 2 quarters · filed 2013-11-14 | $2.09M 10-Q · filed 2013-11-14 | $3.28M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $812.74K 10-Q · filed 2013-08-14 | $1.49M 10-Q · filed 2013-08-14 | $2.68M derived: sum of 3 quarters · filed 2013-08-14 | $3.30M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $676.40K 10-Q · filed 2013-05-14 | $1.87M derived: sum of 2 quarters · filed 2013-05-14 | $2.49M derived: sum of 3 quarters · filed 2013-05-14 | $3.48M derived: sum of 4 quarters · filed 2013-05-14 | ||||
| 2011-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $1.81M derived: sum of 2 quarters · filed 2013-03-14 | $2.80M derived: sum of 3 quarters · filed 2013-03-14 | $3.72M 10-K · filed 2013-03-14 | ||||
| 2011-09-30 | $621.34K 10-Q · filed 2012-11-14 | $2.69M 10-Q · filed 2011-11-10 | $1.61M derived: sum of 2 quarters · filed 2012-11-14 | $2.53M 10-Q · filed 2012-11-14 | $4.59M 10-Q · filed 2011-11-10 | $3.14M derived: sum of 4 quarters · filed 2012-11-14 | ||
| 2011-06-30 | $986.95K 10-Q · filed 2012-08-14 | $1.90M 10-Q · filed 2012-08-14 | $2.52M derived: sum of 3 quarters · filed 2012-08-14 | $3.40M derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | $916.95K 10-Q · filed 2012-05-14 | $1.54M derived: sum of 2 quarters · filed 2012-05-14 | $2.41M derived: sum of 3 quarters · filed 2012-05-14 | $3.30M derived: sum of 4 quarters · filed 2012-05-14 | ||||
| 2010-12-31 | $619.04K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $1.49M derived: sum of 2 quarters · filed 2012-03-14 | $2.39M derived: sum of 3 quarters · filed 2012-03-14 | $3.04M 10-K · filed 2012-03-14 | ||||
| 2010-09-30 | $873.16K 10-Q/A · filed 2012-03-06 | $1.77M derived: sum of 2 quarters · filed 2012-03-06 | $2.42M 10-Q/A · filed 2012-03-06 | |||||
| 2010-06-30 | $894.51K 10-Q/A · filed 2011-09-06 | $1.55M 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |